Literature DB >> 10334745

Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review.

K M Wyatt1, P W Dimmock, P W Jones, P M Shaughn O'Brien.   

Abstract

OBJECTIVE: To evaluate the efficacy of vitamin B-6 in the treatment of premenstrual syndrome.
DESIGN: Systematic review of published and unpublished randomised placebo controlled trials of the effectiveness of vitamin B-6 in the management of premenstrual syndrome.
SUBJECTS: Nine published trials representing 940 patients with premenstrual syndrome. MAIN OUTCOME MEASURES: Proportion of women whose overall premenstrual symptoms showed an improvement over placebo. A secondary analysis was performed on the proportion of women whose premenstrual depressive symptoms showed an improvement over placebo.
RESULTS: Odds ratio relative to placebo for an improvement in overall premenstrual symptoms was 2.32 (95% confidence interval 1.95 to 2.54). Odds ratio relative to placebo for an improvement in depressive symptoms was 1.69 (1.39 to 2.06) from four trials representing 541 patients.
CONCLUSION: Conclusions are limited by the low quality of most of the trials included. Results suggest that doses of vitamin B-6 up to 100 mg/day are likely to be of benefit in treating premenstrual symptoms and premenstrual depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334745      PMCID: PMC27878          DOI: 10.1136/bmj.318.7195.1375

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  36 in total

1.  Pyridoxine and premenstrual tension.

Authors:  J Stokes; J Mendels
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

2.  Oral contraceptives, pyridoxine, and depression.

Authors:  F Winston
Journal:  Am J Psychiatry       Date:  1973-11       Impact factor: 18.112

3.  Low B6 levels in depressed outpatients.

Authors:  J W Stewart; W Harrison; F Quitkin; H Baker
Journal:  Biol Psychiatry       Date:  1984-04       Impact factor: 13.382

4.  [Controlled studies on the oral administration of progestagens, an antiestrogen and vitamin B6 in the treatment of mastodynias].

Authors:  C Colin
Journal:  Rev Med Brux       Date:  1982-11

5.  Pyridoxine in premenstrual depression.

Authors:  J A Mattes; D Martin
Journal:  Hum Nutr Appl Nutr       Date:  1982-04

6.  Pyridoxine megavitaminosis: an analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons.

Authors:  G Krinke; D C Naylor; V Skorpil
Journal:  J Neuropathol Exp Neurol       Date:  1985-03       Impact factor: 3.685

7.  Nutritional factors in the etiology of the premenstrual tension syndromes.

Authors:  G E Abraham
Journal:  J Reprod Med       Date:  1983-07       Impact factor: 0.142

Review 8.  The premenstrual syndrome: a review of the present status of therapy.

Authors:  P M O'Brien
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

9.  Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

Authors:  H Schaumburg; J Kaplan; A Windebank; N Vick; S Rasmus; D Pleasure; M J Brown
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6.

Authors:  U Schaeppi; G Krinke
Journal:  Agents Actions       Date:  1982-10
View more
  29 in total

Review 1.  Gynecological management of premenstrual symptoms.

Authors:  Lee P Shulman
Journal:  Curr Pain Headache Rep       Date:  2010-10

2.  Reporting of systematic reviews of micronutrients and health: a critical appraisal.

Authors:  Mei Chung; Ethan M Balk; Stanley Ip; Gowri Raman; Winifred W Yu; Thomas A Trikalinos; Alice H Lichtenstein; Elizabeth A Yetley; Joseph Lau
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

3.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

4.  Premenstrual syndrome. Evidence-based treatment in family practice.

Authors:  Sue Douglas
Journal:  Can Fam Physician       Date:  2002-11       Impact factor: 3.275

Review 5.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

6.  Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder.

Authors:  Mara Smith; Benicio N Frey
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

7.  Dietary B vitamin intake and incident premenstrual syndrome.

Authors:  Patricia O Chocano-Bedoya; JoAnn E Manson; Susan E Hankinson; Walter C Willett; Susan R Johnson; Lisa Chasan-Taber; Alayne G Ronnenberg; Carol Bigelow; Elizabeth R Bertone-Johnson
Journal:  Am J Clin Nutr       Date:  2011-02-23       Impact factor: 7.045

8.  ISPMD consensus on the management of premenstrual disorders.

Authors:  Tracy Nevatte; Patrick Michael Shaughn O'Brien; Torbjorn Bäckström; Candace Brown; Lorraine Dennerstein; Jean Endicott; C Neill Epperson; Elias Eriksson; Ellen W Freeman; Uriel Halbreich; Khalid Ismail; Nicholas Panay; Teri Pearlstein; Andrea Rapkin; Robert Reid; David Rubinow; Peter Schmidt; Meir Steiner; John Studd; Inger Sundström-Poromaa; Kimberly Yonkers
Journal:  Arch Womens Ment Health       Date:  2013-04-27       Impact factor: 3.633

Review 9.  Complementary and alternative medicine therapies to promote healthy moods.

Authors:  Kathi J Kemper; Scott Shannon
Journal:  Pediatr Clin North Am       Date:  2007-12       Impact factor: 3.278

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.